Société Internationale d’Urologie Journal最新文献_第5页

Outcomes of Robotic Surgery for Low-Volume Surgeons 小容量外科医生的机器人手术效果

Société Internationale d’Urologie Journal Pub Date : 2022-09-14 DOI: 10.48083/ppsc8658

Sridhar Panaiyadiyan, Rajeev Kumar

引用次数: 0

Intra-Diverticular Bladder Tumours: How to Manage Rationally 膀胱憩室内肿瘤:如何合理处理

Société Internationale d’Urologie Journal Pub Date : 2022-09-14 DOI: 10.48083/jclw6772

Mohammed Lotfi Amer, H. Mumtaz, B. Russell, Jason Gan, Z. Rehman, Rajesh M. Nair, R. Thurairaja, Muhammad S. Khan

{"title":"Intra-Diverticular Bladder Tumours: How to Manage Rationally","authors":"Mohammed Lotfi Amer, H. Mumtaz, B. Russell, Jason Gan, Z. Rehman, Rajesh M. Nair, R. Thurairaja, Muhammad S. Khan","doi":"10.48083/jclw6772","DOIUrl":"https://doi.org/10.48083/jclw6772","url":null,"abstract":"Objective To report changing practice in the management of intra-diverticular bladder tumours. Methods We undertook a review of all intra-diverticular bladder tumours in our prospectively maintained institutional database. Results A total of 28 patients (male = 27, female = 1) with a median age of 71 years (IQR 61 to 76) were diagnosed with intra-diverticular bladder tumours (IDBT) between March 2013 and February 2021. Fourteen had visible and 3 had non-visible haematuria, while 11 patients had lower urinary tract symptoms. Median axial diameter of the diverticula was 46 mm (IQR 35 to 69), and median neck diameter was 9 mm (IQR 7 to 11). All patients had CT-urography and 5 patients also had an MRI. Surgical treatment consisted of diverticulectomy (n = 11), diverticulectomy and ipsilateral ureteric reimplantation (n = 11), radical cystectomy and ileal conduit (n = 4), or radical cystectomy and orthotopic bladder (n = 2). Eleven patients had open procedures, and 17 had robotic assisted surgery. Final pathological stages were T0 (n = 2), Ta (n = 5), T1 (n = 7), T3a (n = 8) and T3b (n = 6). Twenty-four patients had urothelial carcinoma (including one nested variant and 4 with squamous differentiation) and 2 had small cell carcinoma. Three patients had neoadjuvant systemic chemotherapy, 2 had intravesical bacillus Calmette-Guerin (BCG) with mitomycin, and one had BCG monotherapy preoperatively. Five patients had adjuvant systemic chemotherapy while 7 had adjuvant intravesical therapies. Mean follow-up period was 37.8 months (±25.3). Mean recurrence-free survival was 61.5% (CI 45.7 to 77.4) and mean overall survival 71.6 % (CI 57.4 to 85.8). Ten patients (37%) died of cancer. Conclusion Management of intra-diverticular bladder tumours is evolving. Bladder-sparing approaches are gaining popularity. Robot-assisted diverticulectomy is preferable as it reduces the morbidity resulting from treatment.","PeriodicalId":21961,"journal":{"name":"Société Internationale d’Urologie Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91553007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Urology in Syria: A View From Inside 叙利亚的泌尿外科:从内部看

Société Internationale d’Urologie Journal Pub Date : 2022-09-14 DOI: 10.48083/irjo4841

Khaled Altopajee, M. Shahait

引用次数: 0

A Quality Assessment of Information Available on Renal Cancer on YouTube YouTube上关于肾癌信息的质量评估

Société Internationale d’Urologie Journal Pub Date : 2022-09-14 DOI: 10.48083/hmug9514

J. Saad, R. Shanmugasundaram, D. Ashrafi, D. Gilbourd

{"title":"A Quality Assessment of Information Available on Renal Cancer on YouTube","authors":"J. Saad, R. Shanmugasundaram, D. Ashrafi, D. Gilbourd","doi":"10.48083/hmug9514","DOIUrl":"https://doi.org/10.48083/hmug9514","url":null,"abstract":"Objectives Many people are turning to alternatives to the conventional doctor-patient relationship, such as webbased search engines and video forums for their health care information. We undertook this study to investigate the quality of videos and information on renal cancer available on the streaming platform YouTube. Methods We completed a search of YouTube (www.YouTube.com) in September 2021 with the term “kidney cancer.” The first 120 videos found which met the inclusion criteria (English speaking, duration greater than one minute, greater than 500 views, renal cancer addressed) were selected. We recorded information including duration, view count, likes, dislikes, comments, publisher, and author. The modified DISCERN tool and Global Quality Score (GQS) questionnaire were used to assess the quality of the included videos. The level of misinformation was assessed using a Likert 5-point scale. Descriptive statistics were used to analyse the collected data. A 2-sample t test was used to further analyse the quality assessment tool results before, during, and after 2016. Results Most videos were published during or after 2016 (63.3%), were predominantly created in North America (77.5%), and were presented by health care professionals (60%). The median length of the videos was 4.23 (1.01 to 65.55) minutes, and the median number of views was 3087 (514 to 228 152). The median number of likes and dislikes was 24 and 5, respectively. The median modified DISCERN score was 3, the median GQS score was 3, and the grading for overall level of misinformation was moderate. Conclusion The quality of information accessed from YouTube on kidney cancer is of a low to moderate overall standard with significant levels of misinformation. YouTube should not be used alone for educational purposes on renal cancer by patients or the public. It is best used in conjunction with information and advice from a medical practitioner and the health care system.","PeriodicalId":21961,"journal":{"name":"Société Internationale d’Urologie Journal","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85237341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Malakoplakia Causing Poor Bladder Compliance and Bilateral Hydroureteronephrosis 斑疹导致膀胱顺应性差和双侧输尿管积水

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/qfcw5582

C. Pham, A. Chung, V. Chalasani

引用次数: 0

The CABEM Initiative: Saving Patients With Muscle-invasive Bladder Cancer CABEM计划:拯救肌肉浸润性膀胱癌患者

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/dfbq7749

F. Korkes, J. H. Santiago, G. Peixoto, F. Timóteo, S. Martins, N. P. Leite, Daisy Barreiros, S. Glina

引用次数: 0

The Value of Conflicts of Interest Disclosures in Oral Presentations at Major Urological Conferences 利益冲突披露在泌尿科主要会议口头报告中的价值

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/spql8302

Anique Le Roux, N. Touma

引用次数: 1

Overnight Ambulatory Urodynamics Change Patient Management Strategies and Improve Symptomatic Outcomes 夜间流动尿动力学改变患者管理策略和改善症状结果

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/rdtd8562

R. Axell, H. Yasmin*, K. Aleksejeva, E. Solomon, B. Toia, M. Thommyppillai, M. Pakzad, R. Hamid, J. Ockrim, T. Greenwell

{"title":"Overnight Ambulatory Urodynamics Change Patient Management Strategies and Improve Symptomatic Outcomes","authors":"R. Axell, H. Yasmin*, K. Aleksejeva, E. Solomon, B. Toia, M. Thommyppillai, M. Pakzad, R. Hamid, J. Ockrim, T. Greenwell","doi":"10.48083/rdtd8562","DOIUrl":"https://doi.org/10.48083/rdtd8562","url":null,"abstract":"ObjectivesTo determine the diagnostic value of overnight ambulatory urodynamics (aUDS) and to assess if a urodynamic diagnosis of detrusor overactivity (DO) or nocturnal enuresis resulted in a change in patient management and an improvement in their urinary symptoms.MethodsA retrospective review of 25 consecutive patients (28% male) with a median age of 38 years (range 18 to 86) having overnight aUDS for bothersome urinary symptoms of primarily nocturia and/or nocturnal enuresis following non-diagnostic conventional urodynamics between November 1998 and August 2018. Urinary symptoms were assessed before overnight aUDS and again after urological treatment following any changes in urodynamics diagnosis and treatment. Six patients were excluded as follow-up data were not available.ResultsTwenty-four patients (96%) presented with nocturia and 20 (80%) presented with nocturnal enuresis. DO was demonstrated in 19 (76%) patients (mean pressure 69.1±53.3 cmH2O). UUI was demonstrated in 16 (80%) out of the 20 patients who complained of nocturnal enuresis. Of the 19 patients with follow-up data, following overnight aUDS a change in urodynamic diagnosis was made in 15 patients (79%); 16 patients (84%) also had their clinical diagnosis and subsequent management changed; and 15 patients (79%) reported an improvement in their urinary symptoms following these changes in diagnosis and treatment. There was a significant improvement in ICIQ-OAB (120±44 versus 32±53, P < 0.0001) scores following the changes to clinical management post-overnight aUDS.ConclusionIn our study cohort, change in primary diagnosis following overnight aUDS led to a significant change in treatment care pathway and resulted in significant improvement in urinary symptoms at follow-up.","PeriodicalId":21961,"journal":{"name":"Société Internationale d’Urologie Journal","volume":"118 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75206872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape 膀胱癌管理中的预测性生物标志物:不断发展的治疗前景的观点

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/rvzv1144

P. Hensley, N. Lobo, K. Bree, W. Tan, P. Gontero, S. Williams, C. C. Guo, G. Giannarini, L. Dyrskjøt, A. Kamat

引用次数: 1

A Systematic Review of Plant-Based Diets and Bladder Cancer: A Call for Further Research 植物性饮食与膀胱癌的系统综述:进一步研究的呼吁

Société Internationale d’Urologie Journal Pub Date : 2022-07-15 DOI: 10.48083/gbma2534

Jacob Taylor, N. Gupta, J. Blanck, S. Loeb

引用次数: 1